These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 18165223)
1. Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions. Raggatt LJ; Qin L; Tamasi J; Jefcoat SC; Shimizu E; Selvamurugan N; Liew FY; Bevelock L; Feyen JH; Partridge NC J Biol Chem; 2008 Mar; 283(11):6790-8. PubMed ID: 18165223 [TBL] [Abstract][Full Text] [Related]
2. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo. Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112 [TBL] [Abstract][Full Text] [Related]
3. Rho and Rho kinase are involved in parathyroid hormone-stimulated protein kinase C alpha translocation and IL-6 promoter activity in osteoblastic cells. Radeff JM; Nagy Z; Stern PH J Bone Miner Res; 2004 Nov; 19(11):1882-91. PubMed ID: 15476589 [TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblasts. Sowa H; Kaji H; Iu MF; Tsukamoto T; Sugimoto T; Chihara K J Biol Chem; 2003 Dec; 278(52):52240-52. PubMed ID: 14517210 [TBL] [Abstract][Full Text] [Related]
5. Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in bone. Yu S; Franceschi RT; Luo M; Fan J; Jiang D; Cao H; Kwon TG; Lai Y; Zhang J; Patrene K; Hankenson K; Roodman GD; Xiao G PLoS One; 2009 Oct; 4(10):e7583. PubMed ID: 19851510 [TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone induces RGS-2 expression by a cyclic adenosine 3',5'-monophosphate-mediated pathway in primary neonatal murine osteoblasts. Tsingotjidou A; Nervina JM; Pham L; Bezouglaia O; Tetradis S Bone; 2002 May; 30(5):677-84. PubMed ID: 11996904 [TBL] [Abstract][Full Text] [Related]
7. The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone. Cho SW; Pirih FQ; Koh AJ; Michalski M; Eber MR; Ritchie K; Sinder B; Oh S; Al-Dujaili SA; Lee J; Kozloff K; Danciu T; Wronski TJ; McCauley LK J Biol Chem; 2013 Mar; 288(10):6814-25. PubMed ID: 23297399 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. Bikle DD; Sakata T; Leary C; Elalieh H; Ginzinger D; Rosen CJ; Beamer W; Majumdar S; Halloran BP J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426 [TBL] [Abstract][Full Text] [Related]
9. Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption. Radeff JM; Nagy Z; Stern PH Exp Cell Res; 2001 Aug; 268(2):179-88. PubMed ID: 11478844 [TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. Qin L; Qiu P; Wang L; Li X; Swarthout JT; Soteropoulos P; Tolias P; Partridge NC J Biol Chem; 2003 May; 278(22):19723-31. PubMed ID: 12644456 [TBL] [Abstract][Full Text] [Related]
11. Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice. Yamaguchi M; Ogata N; Shinoda Y; Akune T; Kamekura S; Terauchi Y; Kadowaki T; Hoshi K; Chung UI; Nakamura K; Kawaguchi H Endocrinology; 2005 Jun; 146(6):2620-8. PubMed ID: 15718274 [TBL] [Abstract][Full Text] [Related]
12. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH. Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180 [TBL] [Abstract][Full Text] [Related]
13. Pregnancy-associated plasma protein-A modulates the anabolic effects of parathyroid hormone in mouse bone. Clifton KB; Conover CA Bone; 2015 Dec; 81():413-416. PubMed ID: 26297833 [TBL] [Abstract][Full Text] [Related]
14. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation. Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro. Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931 [TBL] [Abstract][Full Text] [Related]
16. Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone's anabolic actions in bone implicates TGF-β signaling. Siddiqui JA; Le Henaff C; Johnson J; He Z; Rifkin DB; Partridge NC Bone; 2021 Feb; 143():115762. PubMed ID: 33212319 [TBL] [Abstract][Full Text] [Related]
17. Role of protein kinase A, phospholipase C and phospholipase D in parathyroid hormone receptor regulation of protein kinase Calpha and interleukin-6 in UMR-106 osteoblastic cells. Radeff JM; Singh AT; Stern PH Cell Signal; 2004 Jan; 16(1):105-14. PubMed ID: 14607281 [TBL] [Abstract][Full Text] [Related]